The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study

PHASE3CompletedINTERVENTIONAL
Enrollment

682

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Macular Edema, CystoidRetinal Vein Occlusion
Interventions
OTHER

Standard Care

CRVO: observation; BRVO: standard care

DRUG

intravitreal triamcinolone injection

1 mg dose

DRUG

intravitreal triamcinolone injection

4 mg

Trial Locations (1)

53711

University of Wisconsin, Madison

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

collaborator

Allergan

INDUSTRY

lead

The Emmes Company, LLC

INDUSTRY